Home > Publications > Lamivudine plus Low-Dose Hepatitis B Immunoglobulin to Prevent Recurrent Hepatitis B Following Liver Transplantation.
Centenary Institute - Medical Research
Centenary Institute - Medical Research

Lamivudine plus Low-Dose Hepatitis B Immunoglobulin to Prevent Recurrent Hepatitis B Following Liver Transplantation.

This paper reported the most cost effective protocol to prevent HBV recurrence post transplantation.

Gane EJ, Angus PW, Strasser SI, Crawford DHG, Ring J, Jeffrey GP, McCaughan GW.

Gastroenterology 2007;132:931-937

Date: 2007

//